130 related articles for article (PubMed ID: 16164104)
1. Pap tests and HPV infection. Advances in screening and interpretation.
Buechler EJ
Postgrad Med; 2005 Aug; 118(2):37-40, 43-6. PubMed ID: 16164104
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States.
Irwin K; Montaño D; Kasprzyk D; Carlin L; Freeman C; Barnes R; Jain N; Christian J; Wolters C
Obstet Gynecol; 2006 Aug; 108(2):397-409. PubMed ID: 16880312
[TBL] [Abstract][Full Text] [Related]
3. [HPV test replaces Pap test in Uppsala].
Olovsson M; Aarnio R; Rezapour M; Segeblad B; Sjöö EL; Wilander E
Lakartidningen; 2013 Mar 26-Apr 9; 110(13-14):695-6. PubMed ID: 23634626
[No Abstract] [Full Text] [Related]
4. Human papillomavirus testing in cervical cancer screening.
Castle PE; Cremer M
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):377-90. PubMed ID: 23732037
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL)].
;
Ginekol Pol; 2013 May; 84(5):395-9. PubMed ID: 23819408
[TBL] [Abstract][Full Text] [Related]
6. Toward objective cervical cancer screening: maybe the eyes do have it.
Stoler MH
Am J Clin Pathol; 2010 Jul; 134(1):5-6. PubMed ID: 20551259
[No Abstract] [Full Text] [Related]
7. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
8. The future of the Pap: where is cervical cancer screening headed?
Ruhl C
Nurs Womens Health; 2008 Oct; 12(5):427-31. PubMed ID: 18837722
[No Abstract] [Full Text] [Related]
9. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
10. Cervical screening and human papillomavirus.
Sheary B; Dayan L
Aust Fam Physician; 2005 Jul; 34(7):578-80. PubMed ID: 15999169
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
12. Cervical cytology screening in teens.
Moscicki AB
Curr Womens Health Rep; 2003 Dec; 3(6):433-7. PubMed ID: 14613663
[TBL] [Abstract][Full Text] [Related]
13. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
14. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
15. Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
Westre B; Giske A; Guttormsen H; Wergeland Sørbye S; Skjeldestad FE
PLoS One; 2019; 14(11):e0221546. PubMed ID: 31689301
[TBL] [Abstract][Full Text] [Related]
16. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
[TBL] [Abstract][Full Text] [Related]
18. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
[TBL] [Abstract][Full Text] [Related]
20. Natural history of persistent high-risk human papillomavirus infections in Korean women.
Bae J; Seo SS; Park YS; Dong SM; Kang S; Myung SK; Park SY
Gynecol Oncol; 2009 Oct; 115(1):75-80. PubMed ID: 19619893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]